Literature DB >> 24194425

Complement lesions in cell membranes from joint effusions of various types of arthritis.

R R Dourmashkin1, S Patterson.   

Abstract

Electron microscopy of differentially centrifuged synovial fluid from patients with differing types of arthritis revealed a few membranes bearing complement lesions. It was shown that this is due to activation of the alternate pathway of complement by leukocytic enzymes. It is not clear where the site of action is in inflammatory exudates; it may be on internal membranes of the cells, as no detectable cytotoxic effect could be found using Rb(86) as a marker for specific release. In addition, lysosomal enzymes have the net effect of inhibiting the hemolysis of indicator cells caused by activation of the alternate pathway by inulin.

Entities:  

Year:  1976        PMID: 24194425     DOI: 10.1007/BF00917526

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  11 in total

1.  Chromogenic substrates; phenolphthalein glucuronic acid as substrate for the assay of glucuronidase activity.

Authors:  P TALALAY; W H FISHMAN; C HUGGINS
Journal:  J Biol Chem       Date:  1946-12       Impact factor: 5.157

2.  C3 activation and T-independent B cell stimulation.

Authors:  J Pryjma; J H Humphrey; G G Klaus
Journal:  Nature       Date:  1974-12-06       Impact factor: 49.962

3.  Immunofluorescent localization of the third and the fourth component of complement in synovial tissue from patients with rheumatoid arthritis.

Authors:  W S Rodman; R C Williams; P J Bilka; H J Müller-Eberhard
Journal:  J Lab Clin Med       Date:  1967-01

4.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

5.  Activation of the complement system in rheumatoid synovitis.

Authors:  S Ruddy; K F Austen
Journal:  Fed Proc       Date:  1973-02

6.  Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes.

Authors:  I M Goldstein; G Weissmann
Journal:  J Immunol       Date:  1974-11       Impact factor: 5.422

7.  Production of paroxysmal nocturnal haemoglobinuria-like red cells by reducing and oxidizing agents.

Authors:  B D Goldstein
Journal:  Br J Haematol       Date:  1974-01       Impact factor: 6.998

8.  Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.

Authors:  O Götze; H J Müller-Eberhard
Journal:  N Engl J Med       Date:  1972-01-27       Impact factor: 91.245

9.  Immune lysis of AET-treated normal red cells (PNH-like cells).

Authors:  G Sirchia; J V Dacie
Journal:  Nature       Date:  1967-08-12       Impact factor: 49.962

10.  Breakdown products of C 3 in human synovial fluids.

Authors:  N J Zvaifler
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.